Neutralizing antibodies and T-cell responses to inactivated SARS-CoV-2 vaccine in COVID-19 convalescents one and a half years after infection

Vaccines have been considered the most promising solution for ending the coronavirus disease 2019 (COVID-19) pandemic. Information regarding neutralizing antibodies (NAbs) and T-cell immune response in inactivated SARS-CoV-2 vaccine-immunized COVID-19 convalescent patients were either only available...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Li-Na, Li, Dan, Wang, Zhen-Dong, Jiang, Ze-Zheng, Xiao, Xiao, Yu, Xue-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595495/
https://www.ncbi.nlm.nih.gov/pubmed/36283534
http://dx.doi.org/10.1016/j.virusres.2022.198977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595495/
https://www.ncbi.nlm.nih.gov/pubmed/36283534
http://dx.doi.org/10.1016/j.virusres.2022.198977

Ejemplares similares